Trade Summary

Yesterday, Silverstein Christine Berni, serving as Dir at ABEONA THERAPEUTICS INC. (ABEO), sold 18,160 shares at $5.71 per share, for a total transaction value of $103,695.42. Following this transaction, Silverstein Christine Berni now holds 119,562 shares of ABEO.

This sale represents a 13.19% decrease in Silverstein Christine Berni's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 15, 2026 at 7:48 PM ET, meaning the disclosure happened on the same day as the trade.

ABEONA THERAPEUTICS INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.